Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis

被引:81
作者
Datz, C
Lalloz, MRA
Vogel, W
Graziadei, I
Hackl, F
Vautier, G
Layton, DM
MaierDobersberger, T
Ferenci, P
Penner, E
Sandhofer, F
Bomford, A
Paulweber, B
机构
[1] UNIV LONDON KINGS COLL, SCH MED & DENT, DEPT HAEMATOL MED, LONDON SE5 9PJ, ENGLAND
[2] LKA SALZBURG, DEPT MED, SALZBURG, AUSTRIA
[3] UNIV INNSBRUCK, DEPT INTERNAL MED, A-6020 INNSBRUCK, AUSTRIA
[4] KRANKENHAUS ELISABETHINEN LINZ, DEPT MED, LINZ, AUSTRIA
[5] UNIV VIENNA, DEPT MED, VIENNA, AUSTRIA
[6] UNIV LONDON KINGS COLL, SCH MED & DENT, INST LIVER STUDIES, LONDON SE5 9PJ, ENGLAND
关键词
genetic haemochromatosis; HLA-H; mutation; polymorphism;
D O I
10.1016/S0168-8278(97)80312-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Genetic haemochromatosis is the most common autosomal recessive disorder in Northern European populations, A major histocompatibility complex class I-like gene, HLA-H, has been proposed to be responsible for genetic haemochromatosis. The prevalence of HLA-H gene mutations 282(TGC; Cys/TAC; Tyr) and 63(CAT; His/GAT; Asp) was determined in patients of Austrian origin. Methods: DNA extracted from the blood of 40 Austrian patients and 271 controls was used to amplify HLA-H gene fragments by the polymerase chain reaction method, The base changes responsible for mutations Cys282Tyr and His63Asp alter recognition sites for restriction enzymes SnaB I and Bc1 I, respectively, Digestion products were separated by agarose gel electrophoresis and visualised by ethidium bromide staining. Results: Thirty-one (77.5%) genetic haemochromatosis patients were homozygous for mutation Cys282Tyr and three compound heterozygous for mutations Cys282Tyr and His63Asp. One patient was homozygous for mutation His63Asp but normal for mutation Cys282Tyr, Four patients were normal at both genetic loci and one patient was heterozygous for mutation His63Asp. One control subject homozygous for mutation Cys282Tyr was found on investigation to fulfil diagnostic criteria for haemochromatosis, Eight control subjects homozygous for mutation His63Asp showed no biochemical or clinical evidence of haemochromatosis indicating that this variant is not directly responsible for haemochromatosis, Absence of the Cys282Tyr mutation in six genetic haemochromatosis patients with distinct haplotypes indicates mutations within the HLA-H gene or at alternative genetic loci are the cause of genetic haemochromatosis in these patients. Conclusions: The HLA-H Cys282Tyr defect is likely to play a key role in the pathogenesis of haemochromatosis in most patients, Predominance of a single HLA-H gene mutation in haemochromatosis allows presymptomatic screening by genotypic analysis.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 17 条
[1]  
BACON BR, 1996, HEPATOLOGY TXB LIVER, P1439
[2]  
BEUTLER E, 1996, BLOOD CELL MOL DIS, V22, P187
[3]  
BOMFORD A, 1976, Q J MED, V45, P611
[4]  
BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237
[5]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[6]  
JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347
[7]  
JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428
[8]  
Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249
[9]   Haemochromatosis and HLA-H [J].
Jouanolle, AM ;
Gandon, G ;
Jezequel, P ;
Blayau, M ;
Campion, ML ;
Yaouanq, J ;
Mosser, J ;
Fergelot, P ;
Chauvel, B ;
Bouric, P ;
Carn, G ;
Andrieux, N ;
Gicquel, I ;
LeGall, JY ;
David, V .
NATURE GENETICS, 1996, 14 (03) :251-252
[10]  
McKusick V.A., 1994, MENDELIAN INHERITANC